Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Probionova
Lugano, Ticino, Switzerlandprobionova.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
01
Overview
Probionova develops and produces evidence-based probiotics with pharmaceutical-grade quality, targeting the improvement of human gut and digestive health. The company collaborates with scientific experts to advance research on the human microbiome, offering innovative probiotic formulations for therapeutic and supplement markets. Clinical results are referenced as "evidence-based," but no specific trial outcomes are published in public sources as of June 2025.
- Therapeutic areas
- Gastroenterology
- Modalities
- Live biotherapeutic product therapyMicrobial therapyDietary supplement (probiotic-based)
- Industry
- Biotech
Beyond the preview
Go deeper on Probionova.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Probionova.